Home LiteratureArticle Details
PMID: 9626061 Published · ppublish English Journal Article

Deficient liver regeneration after carbon tetrachloride injury in mice lacking type 1 but not type 2 tumor necrosis factor receptor.

The American journal of pathology ·Vol. 152 ·No. 6 ·1998-06-00 ·Pages 1577-89

Yamada Y, Fausto N

Abstract

Signaling by tumor necrosis factor type 1 receptor (TNFR-1) is required for the initiation of liver regeneration after partial hepatectomy. Using knockout mice that lack either TNFR-1 or TNFR-2, we determined whether signaling through TNF receptors is important for liver injury and hepatocyte proliferation induced by carbon tetrachloride (CCl4). Lack of TNFR-1 inhibited hepatocyte DNA synthesis after CCl4 injection. At 44 hours after the injection, replication of hepatocytes in TNFR-1 was 50% to 90% lower than in wild-type (WT) animals, depending on the dose injected. In WT animals, hepatocyte replication was essentially completed by 4 days after CCl4 injection, but replication at a low level persisted in TNFR-1 mice for at least 2 weeks. TNFR-1 knockout mice had little detectable NF-kappa B and STAT3 binding during the first 5 hours after CCl4, high plasma TNF, and reduced levels of plasma interleukin (IL)-6 and liver IL-6 mRNA. Injection of IL-6 30 minutes before CCl4 administration corrected the deficiency of hepatocyte replication at 44 hours and restored STAT3 binding to normal levels. In contrast, mice lacking TNFR-2 did not differ significantly from WT mice in NF-kappa B and STAT3 binding, IL-6 and TNF levels, or hepatocyte replication. Although AP-1 binding was induced in WT TNFR-1 and TNFR-2 knockout mice, binding in TNFR-2 knockouts was lower than in WT mice. C/EBP binding was much lower in TNFR-1 and TNFR-2 knockout mice than in WT mice. As assessed by morphological analysis and alanine aminotransferase levels, the acute injury caused by CCl4 appeared to be similar in the three groups of animals, but subsequent regeneration was impaired in mice lacking TNFR-1. We conclude that a TNFR-1 signaling pathway involving NF-kappa B, IL-6, and STAT3 is an important component of the hepatocyte mitogenic response induced by CCl4 injury in mouse liver.

MeSH Terms
Alanine Transaminase/blood Animals Carbon Tetrachloride Chemical and Drug Induced Liver Injury DNA/metabolism DNA-Binding Proteins/drug effects,metabolism Interleukin-6/blood,metabolism,pharmacology Liver Diseases/metabolism,pathology,physiopathology Liver Regeneration/drug effects,physiology Mice Mice, Inbred C57BL Mice, Knockout Proto-Oncogene Proteins/metabolism Receptors, Tumor Necrosis Factor/metabolism,physiology STAT3 Transcription Factor Time Factors Trans-Activators/drug effects,metabolism Transcription Factors/metabolism Tumor Necrosis Factor-alpha/analysis
Chemicals
DNA-Binding Proteins Interleukin-6 Proto-Oncogene Proteins Receptors, Tumor Necrosis Factor STAT3 Transcription Factor Stat3 protein, mouse Trans-Activators Transcription Factors Tumor Necrosis Factor-alpha DNA Carbon Tetrachloride Alanine Transaminase
Authors & Affiliations
2 authors, click to expand affiliations / ORCID
Yamada Y
Department of Pathology, University of Washington School of Medicine, Seattle 98195-7705, USA.
Fausto N
References (26)
26 references, click to expand
  1. Rapid activation of the Stat3 transcription complex in liver regeneration.
    Hepatology. 1995 May;21(5):1443-9 PMID: 7737651
  2. Tumor necrosis factor-alpha induces c-jun during the regenerative response to liver injury.
    Am J Physiol. 1994 Oct;267(4 Pt 1):G552-61 PMID: 7943321
  3. Rapid DNA binding by nuclear factor kappa B in hepatocytes at the start of liver regeneration.
    Cell Growth Differ. 1995 Apr;6(4):417-27 PMID: 7794809
  4. Induction of apoptosis in mature T cells by tumour necrosis factor.
    Nature. 1995 Sep 28;377(6547):348-51 PMID: 7566090
  5. Vitamin E therapy of acute CCl4-induced hepatic injury in mice is associated with inhibition of nuclear factor kappa B binding.
    Hepatology. 1995 Nov;22(5):1474-81 PMID: 7590666
  6. The transmembrane form of tumor necrosis factor is the prime activating ligand of the 80 kDa tumor necrosis factor receptor.
    Cell. 1995 Dec 1;83(5):793-802 PMID: 8521496
  7. Transducers of life and death: TNF receptor superfamily and associated proteins.
    Oncogene. 1996 Jan 4;12(1):1-9 PMID: 8552378
  8. Role of lymphotoxin and the type I TNF receptor in the formation of germinal centers.
    Science. 1996 Mar 1;271(5253):1289-91 PMID: 8638112
  9. Tumor necrosis factor receptors (Tnfr) in mouse fibroblasts deficient in Tnfr1 or Tnfr2 are signaling competent and activate the mitogen-activated protein kinase pathway with differential kinetics.
    J Biol Chem. 1996 Nov 8;271(45):28097-104 PMID: 8910423
  10. Liver failure and defective hepatocyte regeneration in interleukin-6-deficient mice.
    Science. 1996 Nov 22;274(5291):1379-83 PMID: 8910279
  11. Tumor necrosis factor (TNF) receptors in cellular signaling of soluble and membrane-expressed TNF.
    J Inflamm. 1995-1996;47(1-2):8-17 PMID: 8913925
  12. Induction of early-immediate genes by tumor necrosis factor alpha contribute to liver repair following chemical-induced hepatotoxicity.
    Hepatology. 1997 Jan;25(1):133-41 PMID: 8985279
  13. Initiation of liver growth by tumor necrosis factor: deficient liver regeneration in mice lacking type I tumor necrosis factor receptor.
    Proc Natl Acad Sci U S A. 1997 Feb 18;94(4):1441-6 PMID: 9037072
  14. Inhibition of NF-kappa B activity induces apoptosis in murine hepatocytes.
    Am J Pathol. 1997 Oct;151(4):891-6 PMID: 9327720
  15. Nuclear factor-kappaB/Rel blocks transforming growth factor beta1-induced apoptosis of murine hepatocyte cell lines.
    Cell Growth Differ. 1997 Oct;8(10):1049-59 PMID: 9342183
  16. Interleukin-6 protects liver against warm ischemia/reperfusion injury and promotes hepatocyte proliferation in the rodent.
    Hepatology. 1997 Dec;26(6):1513-20 PMID: 9397992
  17. Regulated transcription of c-Ki-ras and c-myc during compensatory growth of rat liver.
    Mol Cell Biol. 1984 Aug;4(8):1493-8 PMID: 6493228
  18. A liver-specific factor essential for albumin transcription differs between differentiated and dedifferentiated rat hepatoma cells.
    Genes Dev. 1988 Aug;2(8):957-74 PMID: 3169549
  19. Temporal and spatial patterns of proto-oncogene expression at early stages of toxic liver injury in the rat.
    Lab Invest. 1991 Sep;65(3):324-33 PMID: 1890812
  20. Tumor necrosis factor stimulates DNA synthesis of mouse hepatocytes in primary culture and is suppressed by transforming growth factor beta and interleukin 6.
    J Cell Physiol. 1992 Jan;150(1):134-9 PMID: 1730779
  21. Antibodies to tumor necrosis factor-alpha inhibit liver regeneration after partial hepatectomy.
    Am J Physiol. 1992 Oct;263(4 Pt 1):G579-85 PMID: 1415718
  22. Timing of protooncogene expression varies in toxin-induced liver regeneration.
    J Cell Physiol. 1993 Feb;154(2):294-300 PMID: 8425910
  23. Soluble tumor necrosis factor (TNF) receptors are effective therapeutic agents in lethal endotoxemia and function simultaneously as both TNF carriers and TNF antagonists.
    J Immunol. 1993 Aug 1;151(3):1548-61 PMID: 8393046
  24. Stimulation of human T-cell proliferation by specific activation of the 75-kDa tumor necrosis factor receptor.
    J Immunol. 1993 Nov 1;151(9):4637-41 PMID: 8409424
  25. Tumor necrosis factor, other cytokines and disease.
    Annu Rev Cell Biol. 1993;9:317-43 PMID: 8280464
  26. Prevention of carbon tetrachloride-induced rat liver injury by soluble tumor necrosis factor receptor.
    Gastroenterology. 1995 Jun;108(6):1849-54 PMID: 7768392
Article Info
Journal
The American journal of pathology
Abbr.
Am J Pathol
ISSN
0002-9440
Published
1998-06-00
Pages
1577-89
Language
English
Region
United States
NLM ID
0370502
PMCID
PMC1858451
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com